These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 9239158

  • 41. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
    O'Brien S, Giles F, Talpaz M, Cortes J, Rios MB, Shan J, Thomas D, Andreeff M, Kornblau S, Faderl S, Garcia-Manero G, White K, Mallard S, Freireich E, Kantarjian HM.
    Cancer; 2003 Sep 01; 98(5):888-93. PubMed ID: 12942553
    [Abstract] [Full Text] [Related]

  • 42. [Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
    Maeda A, Yamamoto K, Kotone Y, Yamashita K, Yoshinaga N, Hirata H, Asagoe K, Nohgawa M, Takahashi A, Ohno H, Tashima M, Sasada M.
    Rinsho Ketsueki; 1998 Jun 01; 39(6):442-6. PubMed ID: 9695673
    [Abstract] [Full Text] [Related]

  • 43. [Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].
    Hasegawa A, Ninomiya H, Yanagisawa K, Takada K, Hasegawa H, Hato T, Yasukawa M, Fujita S.
    Rinsho Ketsueki; 1996 Sep 01; 37(9):853-7. PubMed ID: 8914475
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Interferon treatment in chronic myeloid leukemia].
    Simonsson B.
    Nord Med; 1992 Sep 01; 107(3):76-7, 79. PubMed ID: 1549456
    [Abstract] [Full Text] [Related]

  • 47. Ten-year follow-up of a single center prospective trial of unmanipulated peripheral blood stem cell autograft and interferon-alpha in early phase chronic myeloyd leukemia.
    Meloni G, Capria S, Vignetti M, Alimena G, de Fabritiis P, Montefusco E, Mandelli F.
    Haematologica; 2001 Jun 01; 86(6):596-601. PubMed ID: 11418368
    [Abstract] [Full Text] [Related]

  • 48. No known cause: leukemia research.
    Tecnologica; 2000 Jun 01; ():1, 3-6, 14. PubMed ID: 11010680
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Chronic myelogenous leukemia].
    Ohnishi K.
    Gan To Kagaku Ryoho; 2001 Sep 01; 28(9):1199-205. PubMed ID: 11579630
    [Abstract] [Full Text] [Related]

  • 52. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses.
    Peñarrubia MJ, Odriozola J, González C, Massagué I, Miguel A, González San Miguel JD, Pérez Encinas M, Lavilla E, Giraldo MP, Casado LF, Ferrer S, Steegmann JL, Spanish Group on IFN and CML.
    Ann Hematol; 2003 Dec 01; 82(12):750-8. PubMed ID: 14517691
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Bone marrow transplantation in chronic myeloid leukemia].
    Milone JH, Bordone J, Etchegoyen O, Napal J, Prates MV, Morales VH.
    Medicina (B Aires); 1999 Dec 01; 59(1):1-10. PubMed ID: 10349111
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
    Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Cheron N, Nicolini F, Abgrall JF, Tanzer J.
    N Engl J Med; 1997 Jul 24; 337(4):223-9. PubMed ID: 9227927
    [Abstract] [Full Text] [Related]

  • 58. Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group.
    Hehlmann R, Kister P, Willer A, Simon M, Schenk M, Seifarth W, Papakonstantinou G, Saussele S, Kolb HJ, Ansari H.
    Leukemia; 1994 Apr 24; 8 Suppl 1():S127-32. PubMed ID: 8152279
    [Abstract] [Full Text] [Related]

  • 59. Chronic myelogenous leukemia: a review.
    Cortes JE, Talpaz M, Kantarjian H.
    Am J Med; 1996 May 24; 100(5):555-70. PubMed ID: 8644769
    [Abstract] [Full Text] [Related]

  • 60. [The assessment of therapeutic success in chronic myeloid leukemia].
    Griesshammer M, Hehlmann R, Heimpel H.
    Dtsch Med Wochenschr; 1995 Apr 28; 120(17):620-5. PubMed ID: 7537652
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.